Predicting the development of adverse cardiac events in patients with hypertrophic cardiomyopathy using machine learning. (15th March 2021)

• Record Type: Journal Article
• Authors: Kochav, Stephanie M.; Raita, Yoshihiko; Fifer, Michael A.; Takayama, Hiroo; Ginns, Jonathan; Maurer, Mathew S.; Reilly, Muredach P.; Hasegawa, Kohei; Shimada, Yuichi J.
• Is Part Of: International journal of cardiology. Volume 327(2021)
• Page Start: 117
• Page End: 124
• Publication Date: 2021-03-15
• Subjects: Hypertrophic cardiomyopathy -- Adverse cardiac event -- Prediction -- Machine learning; Cardiology -- Periodicals; Electronic journals; 616.12
• DOI: 10.1016/j.ijcard.2020.11.003
• Languages: English
• ISSNs: 0167-5273

Abstract

Abstract: Background: Only a subset of patients with hypertrophic cardiomyopathy (HCM) develop adverse cardiac events – e.g., end-stage heart failure, cardiovascular death. Current risk stratification methods are imperfect, limiting identification of high-risk patients with HCM. Our aim was to improve the prediction of adverse cardiac events in patients with HCM using machine learning methods. Methods: We applied modern machine learning methods to a prospective cohort of adults with HCM. The outcome was a composite of death due to heart failure, heart transplant, and sudden death. As the reference model, we constructed logistic regression model using known predictors. We determined 20 predictive characteristics based on random forest classification and a priori knowledge, and developed 4 machine learning models. Results Of 183 patients in the cohort, the mean age was 53 (SD = 17) years and 45% were female. During the median follow-up of 2.2 years (interquartile range, 0.6–3.8), 33 subjects (18%) developed an outcome event, the majority of which (85%) was heart transplant. The predictive accuracy of the reference model was 73% (sensitivity 76%, specificity 72%) while that of the machine learning model was 85% (e.g., sensitivity 88%, specificity 84% with elastic net regression). All 4 machine learning models significantly outperformed the reference model – e.g., area under the receiver-operating-characteristic curve 0.79 with the reference model vs. 0.93 with elastic net regression ( p < 0.001). Conclusions: Compared with conventional risk stratification, the machine learning models demonstrated a superior ability to predict adverse cardiac events. These modern machine learning methods may enhance identification of high-risk HCM subpopulations. Highlights: We applied modern machine learning methods to hypertrophic cardiomyopathy. Machine learning improves risk prediction of adverse cardiac events. Such novel methods enhance identification of high-risk patients with hypertrophic cardiomyopathy.